Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1977 1
1981 1
1987 1
1988 2
1990 1
1991 6
1992 4
1993 4
1995 2
1996 2
1997 6
1998 1
1999 3
2000 1
2002 1
2003 1
2005 1
2006 2
2007 2
2008 3
2009 1
2010 1
2011 1
2012 1
2013 1
2014 4
2016 3
2017 3
2018 2
2019 3
2020 6
2021 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Fungal infections in HIV/AIDS.
Limper AH, Adenis A, Le T, Harrison TS. Limper AH, et al. Lancet Infect Dis. 2017 Nov;17(11):e334-e343. doi: 10.1016/S1473-3099(17)30303-1. Epub 2017 Jul 31. Lancet Infect Dis. 2017. PMID: 28774701 Free article. Review.
Extrapulmonary pneumocystosis.
Ng VL, Yajko DM, Hadley WK. Ng VL, et al. Clin Microbiol Rev. 1997 Jul;10(3):401-18. doi: 10.1128/CMR.10.3.401. Clin Microbiol Rev. 1997. PMID: 9227859 Free PMC article. Review.
Pneumocystosis.
Bernard EM, Sepkowitz KA, Telzak EE, Armstrong D. Bernard EM, et al. Med Clin North Am. 1992 Jan;76(1):107-19. doi: 10.1016/s0025-7125(16)30374-1. Med Clin North Am. 1992. PMID: 1727534 Review.
Adjunctive steroids are useful for treatment of moderate to severe pneumocystosis, but clinicians should be alert to the possibility of activation of other latent infections during and after courses of steroids. Both aerosol pentamidine and trimethoprim-sulfamethoxazole ar …
Adjunctive steroids are useful for treatment of moderate to severe pneumocystosis, but clinicians should be alert to the possibility of acti …
An estimation of burden of serious fungal infections in France.
Gangneux JP, Bougnoux ME, Hennequin C, Godet C, Chandenier J, Denning DW, Dupont B; LIFE program, the Société française de mycologie médicale SFMM-study group. Gangneux JP, et al. J Mycol Med. 2016 Dec;26(4):385-390. doi: 10.1016/j.mycmed.2016.11.001. Epub 2016 Nov 22. J Mycol Med. 2016. PMID: 27887809 Review.
Where no data existed, we used specific populations at risk and fungal infection frequencies in those populations to estimate national incidence or prevalence, depending on the condition. RESULTS: The model predicts high prevalences of severe asthma with fungal sensitizati …
Where no data existed, we used specific populations at risk and fungal infection frequencies in those populations to estimate national incid …
Lung and sinus fungal infection imaging in immunocompromised patients.
Lamoth F, Prakash K, Beigelman-Aubry C, Baddley JW. Lamoth F, et al. Clin Microbiol Infect. 2024 Mar;30(3):296-305. doi: 10.1016/j.cmi.2023.08.013. Epub 2023 Aug 20. Clin Microbiol Infect. 2024. PMID: 37604274 Review.
Regarding sinus site, bony erosion, peri-antral fat or septal ulceration are reasonably predictive of IFD. IMPLICATIONS: Imaging assessment of the lung and sinuses is an important component of the diagnostic work-up and management of IFD in immunocompromised patients. ...
Regarding sinus site, bony erosion, peri-antral fat or septal ulceration are reasonably predictive of IFD. IMPLICATIONS: Imaging asse …
Invasive fungal diseases during COVID-19: We should be prepared.
Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Gangneux JP, et al. J Mycol Med. 2020 Jun;30(2):100971. doi: 10.1016/j.mycmed.2020.100971. Epub 2020 Apr 6. J Mycol Med. 2020. PMID: 32307254 Free PMC article. No abstract available.
Cutaneous pneumocystosis.
Coulman CU, Greene I, Archibald RW. Coulman CU, et al. Ann Intern Med. 1987 Mar;106(3):396-8. doi: 10.7326/0003-4819-106-3-396. Ann Intern Med. 1987. PMID: 3492951
Biopsy of the right ear mass detected Pneumocystis carinii. The patient was treated with a 7-day course of intravenous trimethoprim, followed by a 3-week course of oral trimethoprim-sulfamethoxazole, with a marked reduction in the size of his ear masses. ...
Biopsy of the right ear mass detected Pneumocystis carinii. The patient was treated with a 7-day course of intravenous trimethoprim, …
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis.
Buonomo AR, Zappulo E, Viceconte G, Scotto R, Borgia G, Gentile I. Buonomo AR, et al. Expert Opin Drug Saf. 2018 Jul;17(7):709-717. doi: 10.1080/14740338.2018.1483330. Epub 2018 Jun 11. Expert Opin Drug Saf. 2018. PMID: 29848085 Review.
Nevertheless, several post-marketing reports documented cases of serious, rare, and unexpected infections. EXPERT OPINION: Predictive risk factors and prognostic features of opportunistic infections in this setting still need to be exactly assessed. ...
Nevertheless, several post-marketing reports documented cases of serious, rare, and unexpected infections. EXPERT OPINION: Predictive …
Burden of fungal infections in Iran.
Hedayati MT, Taghizadeh Armaki M, Yazdani Charati J, Hedayati N, Seyedmousavi S, Denning DW. Hedayati MT, et al. J Infect Dev Ctries. 2018 Oct 31;12(10):910-918. doi: 10.3855/jidc.10476. J Infect Dev Ctries. 2018. PMID: 32004161 Free article.
COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
Bretagne S, Sitbon K, Botterel F, Dellière S, Letscher-Bru V, Chouaki T, Bellanger AP, Bonnal C, Fekkar A, Persat F, Costa D, Bourgeois N, Dalle F, Lussac-Sorton F, Paugam A, Cassaing S, Hasseine L, Huguenin A, Guennouni N, Mazars E, Le Gal S, Sasso M, Brun S, Cadot L, Cassagne C, Cateau E, Gangneux JP, Moniot M, Roux AL, Tournus C, Desbois-Nogard N, Le Coustumier A, Moquet O, Alanio A, Dromer F; French Mycoses Study Group. Bretagne S, et al. Microbiol Spectr. 2021 Oct 31;9(2):e0113821. doi: 10.1128/Spectrum.01138-21. Epub 2021 Oct 20. Microbiol Spectr. 2021. PMID: 34668768 Free PMC article.
The mortality rates were 76.7% (23/30) in patients with host factors for invasive fungal disease, 45.2% (14/31) in those with a preexisting pulmonary condition, and 36.6% (34/93) in the remaining patients (P = 0.001). Antimold treatment did not alter prognosis (P = 0.370). …
The mortality rates were 76.7% (23/30) in patients with host factors for invasive fungal disease, 45.2% (14/31) in those with a preexisting …
80 results